Zillion Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 15.97%
- Profit Growth 116.12%
- Ebitda 143.96%
- Net Worth 1.99%
- Total Assets 37.57%
About Zillion Life Sciences
Zillion Life Sciences Private Limited (ZLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 September 2013 and has a history of 11 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Mishra, Madanmohan Jha, and Maha Kumari serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233MH2013PTC247983
-
Company No.
247983
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Sep 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Zillion Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Mishra
|
Director | 06-Sep-2013 | Current |
|
Madanmohan Jha
|
Director | 01-Jan-2015 | Current |
|
Maha Kumari
|
Director | 06-Sep-2013 | Current |
Financial Performance of Zillion Life Sciences.
Zillion Life Sciences Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 15.97% increase. The company also saw a substantial improvement in profitability, with a 116.12% increase in profit. The company's net worth moved up by a moderate rise of 1.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zillion Life Sciences?
In 2017, Zillion Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Makesson Healthcure Private LimitedAnil Mishra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zillion Life Sciences?
Unlock and access historical data on people associated with Zillion Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zillion Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zillion Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.